 
Institution: EMORY UNIV | Sign In via User Name/Password 
  
  	Donate 	Help 	Contact The AHA 	Sign In 	Home 
	American Heart Association 
Stroke 
Search: search_blue_button Advanced Search 
 
    Stroke Home nav_button 
    Subscriptions nav_button 
    Archives nav_button 
    Feedback nav_button 
    Authors nav_button 
    Help nav_button 
    AHA Journals Home 
 
« Previous Article | Table of Contents | Next Article » 
Stroke. 2002;33:831-836 
doi: 10.1161/hs0302.104542 
This Article 
Right arrow 	Full Text 
Right arrow 	Full Text (PDF) 
Right arrow 	Alert me when this article is cited 
Right arrow 	Alert me if a correction is posted 
Right arrow 	Citation Map 
Services 
Right arrow 	Email this article to a friend 
Right arrow 	Similar articles in this journal 
Right arrow 	Similar articles in PubMed 
Right arrow 	Alert me to new issues of the journal 
Right arrow 	Download to citation manager 
Right arrow 	Request Permissions 
Citing Articles 
Right arrow 	Citing Articles via HighWire 
Right arrow 	Citing Articles via Google Scholar 
Google Scholar 
Right arrow 	Articles by Sumii, T. 
Right arrow 	Articles by Lo, E. H. 
Right arrow 	Search for Related Content 
PubMed 
Right arrow 	PubMed Citation 
Right arrow 	Articles by Sumii, T. 
Right arrow 	Articles by Lo, E. H. 
Right arrow 	Pubmed/NCBI databases 
* Compound via MeSH 
* Substance via MeSH 
Hazardous Substances DB 
* (L)-PHENYLALANINE 
* THIOPHENE 
Related Collections 
Right arrow 	Embolic stroke 
Right arrow 	Intracerebral Hemorrhage 
Right arrow 	Pathology of Stroke 
Right arrow 	Neuroprotectors 
Right arrow 	Thrombolysis 
 
( Stroke. 2002;33:831.) 
© 2002 American Heart Association, Inc. 
Original Contributions 
Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats 
Toshihisa Sumii, MD, PhD Eng H. Lo, PhD 
 
From the Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital, Charlestown (T.S., E.H.L.); Program in Neuroscience, Harvard Medical School, Boston, Mass (E.H.L.); and Department of Neurosurgery, Kinki University School of Medicine, Osaka-Sayama, Japan (T.S.). 
 
Correspondence to Eng H. Lo, PhD, Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Harvard Medical School, MGH East 149-2322, Charlestown, MA 02129. E-mail Lo{at}helix.mgh.harvard.edu 
 
Background and Purpose — Thrombolytic therapy with tissue plasminogen activator (tPA) for acute ischemic stroke remains complicated by risks of hemorrhagic transformation. In this study we used a previously established quantitative rat model of tPA-associated hemorrhage to test the hypothesis that matrix metalloproteinases (MMPs) are involved. 
 
Methods — Spontaneously hypertensive rats were subjected to embolic focal ischemia by placing homologous blood clots into the middle cerebral artery. Three groups of rats were studied: (1) untreated controls that received saline at 6 hours after ischemia; (2) rats that received tPA alone (10 mg/kg at 6 hours after ischemia); and (3) rats that received tPA plus the broad-spectrum MMP inhibitor BB-94 (50 mg/kg of BB-94 before ischemia and at 3 and 6 hours after ischemia plus tPA at 6 hours). Gelatin zymography was used to quantify MMP levels. A hemoglobin spectrophotometry method was used to quantify cerebral hemorrhage. Ischemic lesions were measured at 24 hours with tetrazolium staining. 
 
Results — At 6, 12, and 24 hours, pro-MMP-9 and cleaved MMP-9 were upregulated in ischemic brain. At 12 hours, tPA-treated rats showed significantly higher levels of pro-MMP-9 and cleaved MMP-9 than untreated controls. By 24 hours, all rats showed evidence of hemorrhagic transformation in the ischemic territory. Rats treated with BB-94 and tPA showed significantly reduced hemorrhage volumes compared with those that received tPA alone. There was no effect on infarct size. 
 
Conclusions — These results indicate that (1) tPA treatment increases levels of MMP-9 after embolic focal cerebral ischemia, (2) MMPs are involved in the mechanism of tPA-associated hemorrhage, and (3) combination therapies with MMP inhibitors may be useful for decreasing the risk and severity of this dreaded complication of thrombolytic therapy. 
 
 
Key Words: cerebral hemorrhage • extracellular matrix • reperfusion injury • stroke • tissue plasminogen activator • rats 
 
 
 
 
This article has been cited by other articles: 
 
 
		Home page 
		Stroke Home page 
L. Jia, M. Chopp, L. Zhang, M. Lu, and Z. Zhang 
Erythropoietin in Combination of Tissue Plasminogen Activator Exacerbates Brain Hemorrhage When Treatment Is Initiated 6 Hours After Stroke 
Stroke, September 1, 2010; 41(9): 2071 - 2076. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Biol. Chem. Home page 
M. Hernandez-Guillamon, S. Mawhirt, S. Fossati, S. Blais, M. Pares, A. Penalba, M. Boada, P.-O. Couraud, T. A. Neubert, J. Montaner, et al. 
Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-{beta} E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells 
J. Biol. Chem., August 27, 2010; 285(35): 27144 - 27158. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Leukoc. Biol. Home page 
R. Jin, G. Yang, and G. Li 
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells 
J. Leukoc. Biol., May 1, 2010; 87(5): 779 - 789. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Pharmacol. Exp. Ther. Home page 
R. Liu, Q. Liu, S. He, J. W. Simpkins, and S.-H. Yang 
Combination Therapy of 17{beta}-Estradiol and Recombinant Tissue Plasminogen Activator for Experimental Ischemic Stroke 
J. Pharmacol. Exp. Ther., March 1, 2010; 332(3): 1006 - 1012. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
T. L. Barr, L. L. Latour, K.-Y. Lee, T. J. Schaewe, M. Luby, G. S. Chang, Z. El-Zammar, S. Alam, J. M. Hallenbeck, C. S. Kidwell, et al. 
Blood-Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9 
Stroke, March 1, 2010; 41(3): e123 - e128. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Blood Home page 
Y. Suzuki, N. Nagai, K. Yamakawa, J. Kawakami, H. R. Lijnen, and K. Umemura 
Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein 
Blood, October 8, 2009; 114(15): 3352 - 3358. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
L. S. Machado, I. Y. Sazonova, A. Kozak, D. C. Wiley, A. B. El-Remessy, A. Ergul, D. C. Hess, J. L. Waller, and S. C. Fagan 
Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential 
Stroke, September 1, 2009; 40(9): 3028 - 3033. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Neurology Home page 
C. Foerch, J. Montaner, K. L. Furie, M. M. Ning, and E. H. Lo 
Invited Article: Searching for oracles?: Blood biomarkers in acute stroke 
Neurology, August 4, 2009; 73(5): 393 - 399. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Neurosci. Home page 
D. Yang, N. Nemkul, A. Shereen, A. Jone, R. S. Dunn, D. A. Lawrence, D. Lindquist, and C.-Y. Kuan 
Therapeutic Administration of Plasminogen Activator Inhibitor-1 Prevents Hypoxic-Ischemic Brain Injury in Newborns 
J. Neurosci., July 8, 2009; 29(27): 8669 - 8674. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
T. M. Hemmen and P. D. Lyden 
Multimodal Neuroprotective Therapy With Induced Hypothermia After Ischemic Stroke 
Stroke, March 1, 2009; 40(3_suppl_1): S126 - S128. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
Y. Murata, A. Rosell, R. H. Scannevin, K. J. Rhodes, X. Wang, and E. H. Lo 
Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke 
Stroke, December 1, 2008; 39(12): 3372 - 3377. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Neurol. Neurosurg. Psychiatry Home page 
L Derex and N Nighoghossian 
Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update 
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1093 - 1099. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Neurosci. Home page 
B. W. McColl, N. J. Rothwell, and S. M. Allan 
Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice 
J. Neurosci., September 17, 2008; 28(38): 9451 - 9462. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Leukoc. Biol. Home page 
E. Cuadrado, L. Ortega, M. Hernandez-Guillamon, A. Penalba, I. Fernandez-Cadenas, A. Rosell, and J. Montaner 
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release 
J. Leukoc. Biol., July 1, 2008; 84(1): 207 - 214. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
A. Rosell, E. Cuadrado, A. Ortega-Aznar, M. Hernandez-Guillamon, E. H. Lo, and J. Montaner 
MMP-9-Positive Neutrophil Infiltration Is Associated to Blood-Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke 
Stroke, April 1, 2008; 39(4): 1121 - 1126. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		FASEB J. Home page 
K. Liu, S. Mori, H. K. Takahashi, Y. Tomono, H. Wake, T. Kanke, Y. Sato, N. Hiraga, N. Adachi, T. Yoshino, et al. 
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats 
FASEB J, December 1, 2007; 21(14): 3904 - 3916. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
C. Z. Lee, Z. Xue, Y. Zhu, G.-Y. Yang, and W. L. Young 
Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage 
Stroke, September 1, 2007; 38(9): 2563 - 2568. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
B.-Q. Zhao, E. Tejima, and E. H. Lo 
Neurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke 
Stroke, February 1, 2007; 38(2): 748 - 752. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
T. M. Hemmen and P. D. Lyden 
Induced Hypothermia for Acute Stroke 
Stroke, February 1, 2007; 38(2): 794 - 799. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Neurology Home page 
E. Carrera, P. Michel, P. -A. Despland, M. Maeder-Ingvar, C. Ruffieux, D. Debatisse, J. Ghika, G. Devuyst, and J. Bogousslavsky 
Continuous assessment of electrical epileptic activity in acute stroke. 
Neurology, July 11, 2006; 67(1): 99 - 104. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
S. Wang, S.-R. Lee, S.-Z. Guo, W. J. Kim, J. Montaner, X. Wang, and E. H. Lo 
Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes 
Stroke, July 1, 2006; 37(7): 1910 - 1912. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Neurology Home page 
M. Ning, K. L. Furie, W. J. Koroshetz, H. Lee, M. Barron, M. Lederer, X. Wang, M. Zhu, A. G. Sorensen, E. H. Lo, et al. 
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke 
Neurology, May 23, 2006; 66(10): 1550 - 1555. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		J. Neurosci. Home page 
S.-R. Lee, H.-Y. Kim, J. Rogowska, B.-Q. Zhao, P. Bhide, J. M. Parent, and E. H. Lo 
Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. 
J. Neurosci., March 29, 2006; 26(13): 3491 - 3495. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
K. Tsuji, T. Aoki, E. Tejima, K. Arai, S.-R. Lee, D. N. Atochin, P. L. Huang, X. Wang, J. Montaner, and E. H. Lo 
Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia 
Stroke, September 1, 2005; 36(9): 1954 - 1959. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Circulation Home page 
K. Benchenane, V. Berezowski, C. Ali, M. Fernandez-Monreal, J. P. Lopez-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E. T. MacKenzie, G. Bu, et al. 
Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis 
Circulation, May 3, 2005; 111(17): 2241 - 2249. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
D. C. Alsop, E. Makovetskaya, S. Kumar, M. Selim, and G. Schlaug 
Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke 
Stroke, April 1, 2005; 36(4): 746 - 750. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
L. Zhang, Z. G. Zhang, C. Zhang, R. L. Zhang, and M. Chopp 
Intravenous Administration of a GPIIb/IIIa Receptor Antagonist Extends the Therapeutic Window of Intra-Arterial Tenecteplase-Tissue Plasminogen Activator in a Rat Stroke Model 
Stroke, December 1, 2004; 35(12): 2890 - 2895. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
X. Wang, K. Tsuji, S.-R. Lee, M. Ning, K. L. Furie, A. M. Buchan, and E. H. Lo 
Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke 
Stroke, November 1, 2004; 35(11_suppl_1): 2726 - 2730. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
M. Castellanos, R. Leira, J. Serena, M. Blanco, S. Pedraza, J. Castillo, and A. Davalos 
Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke 
Stroke, July 1, 2004; 35(7): 1671 - 1676. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
M. Dittmar, G. Kiourkenidis, M. Horn, S. Bollwein, G. Bernhardt, G. A. Rosenberg, and T. Pfefferkorn 
Cerebral Ischemia, Matrix Metalloproteinases, and TNF-{alpha}: MMP Inhibitors May Act Not Exclusively by Reducing MMP Activity * Response 
Stroke, July 1, 2004; 35(7): e338 - e340. 
[Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
C. M. Maier, L. Hsieh, F. Yu, P. Bracci, and P. H. Chan 
Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia 
Stroke, May 1, 2004; 35(5): 1169 - 1174. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Blood Home page 
B.-Q. Zhao, Y. Ikeda, H. Ihara, T. Urano, W. Fan, S. Mikawa, Y. Suzuki, K. Kondo, K. Sato, N. Nagai, et al. 
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice 
Blood, April 1, 2004; 103(7): 2610 - 2616. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Am. J. Neuroradiol. Home page 
G. H. Danton and W. D. Dietrich 
The Search for Neuroprotective Strategies in Stroke 
AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 181 - 194. 
[Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
E. H. Lo, J. P. Broderick, and M. A. Moskowitz 
tPA and Proteolysis in the Neurovascular Unit 
Stroke, February 1, 2004; 35(2): 354 - 356. 
[Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
J. Montaner, I. Fernandez-Cadenas, C. A. Molina, J. Monasterio, J. F. Arenillas, M. Ribo, M. Quintana, P. Chacon, A. L. Andreu, and J. Alvarez-Sabin 
Safety Profile of Tissue Plasminogen Activator Treatment Among Stroke Patients Carrying a Common Polymorphism (C-1562T) in the Promoter Region of the Matrix Metalloproteinase-9 Gene 
Stroke, December 1, 2003; 34(12): 2851 - 2855. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet 
Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function 
Stroke, December 1, 2003; 34(12): 2975 - 2979. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
T. Pfefferkorn and G. A. Rosenberg 
Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion 
Stroke, August 1, 2003; 34(8): 2025 - 2030. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Circulation Home page 
L. Zhang, Z. G. Zhang, R. Zhang, D. Morris, M. Lu, B. S. Coller, and M. Chopp 
Adjuvant Treatment With a Glycoprotein IIb/IIIa Receptor Inhibitor Increases the Therapeutic Window for Low-Dose Tissue Plasminogen Activator Administration in a Rat Model of Embolic Stroke 
Circulation, June 10, 2003; 107(22): 2837 - 2843. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Am. J. Neuroradiol. Home page 
K. D. Vo, F. Santiago, W. Lin, C. Y. Hsu, Y. Lee, and J.-M. Lee 
MR Imaging Enhancement Patterns as Predictors of Hemorrhagic Transformation in Acute Ischemic Stroke 
AJNR Am. J. Neuroradiol., April 1, 2003; 24(4): 674 - 679. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Circulation Home page 
J. Montaner, C. A. Molina, J. Monasterio, S. Abilleira, J. F. Arenillas, M. Ribo, M. Quintana;, and J. Alvarez-Sabin 
Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke 
Circulation, February 4, 2003; 107(4): 598 - 603. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
M. Castellanos, R. Leira, J. Serena, J. M. Pumar, I. Lizasoain, J. Castillo, A. Davalos, and G. F. Hamann 
Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke * Editorial Comment 
Stroke, January 1, 2003; 34(1): 40 - 46. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
T. Aoki, T. Sumii, T. Mori, X. Wang, and E. H. Lo 
Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats 
Stroke, November 1, 2002; 33(11): 2711 - 2717. 
[Abstract] [Full Text] [PDF] 
	 
 
		Home page 
		Stroke Home page 
R. M. Dijkhuizen, M. Asahi, O. Wu, B. R. Rosen, and E. H. Lo 
Rapid Breakdown of Microvascular Barriers and Subsequent Hemorrhagic Transformation After Delayed Recombinant Tissue Plasminogen Activator Treatment in a Rat Embolic Stroke Model 
Stroke, August 1, 2002; 33(8): 2100 - 2104. 
[Abstract] [Full Text] [PDF] 
	 
 
 
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search 
Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. 
